Cause–effect studies and deep understanding of the mechanisms are needed to target leptin to modify the venous status.[45] Our study also suggests that inhibition of the prothrombotic effects of leptin may represent a novel therapeutic strategy for reducing DVT after TKA. This evidence concerns the gene LEP and deep vein thrombosis.